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Abstract.  Bioisosteres are functional groups or atoms that are structurally different but that 
can form similar intermolecular interactions.  Potential bioisosteres were identified here from 
analysing the X-ray crystallographic structures for sets of different ligands complexed with a 
fixed protein.  The protein was used to align the ligands with each other, and then pairs of 
ligands compared to identify substructural features with high volume overlap that occurred 
in approximately the same region of geometric space.  The resulting pairs of substructural 
features can suggest potential bioisosteric replacements for use in lead-optimisation studies.  
Experiments with twelve sets of ligand-protein complexes from the Protein Data Bank 
demonstrate the effectiveness of the procedure.  
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INTRODUCTION 
 
Bioisosteres were originally defined as molecules or functional groups that have similar 
chemical and physical properties and that hence exhibit similar biological activities [1, 2].  
This definition has since been extended to include substructural features that are structurally 
different but that can form similar intermolecular interactions.  The concept of bioisosterism 
is an important approach in the lead-optimisation stage of a drug-design programme as it 
provides a way of enhancing some desirable chemical or physical property, e.g. to improve 
solubility or metabolic stability, whilst still maintaining the biological activity of interest [3].  
For example, Merderski et al. reported the use of the benzothiadiazole group as a bioisoster 
for the methylendioxyphenyl group in a study of endothelin receptor antagonists [4]; Uddin 
et al. described the use of the sulfonylazide group as a booster for the sulphonamide group in 
a study of celecoxib analogues [5]; and Showell and Mills advocated the use of silicon as a 
replacement for a fully substituted sp3 carbon [6].  The use of bioisosterism to support lead 
optimisation will also be the focus of the work reported here.  It is, however, worth noting 
that there is now also increasing interest in the use of scaffold-hopping techniques to suggest 
replacement ring systems that can locate functionality at the appropriate locations in 3D 
space whilst providing a novel patent position (see, e.g., [7-9]).   
 
A convenient source of bioisosteres is the BIOSTER database from Accelrys Inc., which 
details pairs of compounds that have been reported in the literature as being biologically 
interchangeable [10].  The current version of the database, Version 2003.1, contains almost 
eleven-thousand pairs of potential bioisosteres, including drugs, agrochemicals and enzyme 
inhibitors [11].  Alternatively, means can be found to identify bioisosteres automatically and 
a range of approaches have been described that are based on calculating measures of 
similarity between pairs of substituents to find those that are closely related using the chosen 
similarity measure.  Then, given an existing bioactive molecule, potential analogues are 
obtained by replacing one or more of the substituents on a central scaffold by those 
substituents that have previously been shown to be most similar.  There have been several 
reports of such techniques, differing principally in the types of information that are used for 
the calculation of the inter-substituent similarities.    
 
The simplest way of measuring the similarity between a pair of substituents uses the 2D 
fingerprint measures that are widely used for similarity searching in chemical databases.  
Such an approach has been reported recently by Wagener and Lommerse, who describe a 
system that has been developed at Organon for suggesting bioisosteric replacements and that 
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is based on fingerprints encoding topological pharmacophore information about the atoms 
comprising a substituent [12].  In another topology-based study, Sheridan analysed pairs of 
molecules that belonged to the same activity class in the MDL Drug Data Report (MDDR) 
database and that differed in only one location [13].  Use of a maximum common 
substructure algorithm identified the common parts of the two molecules that were being 
compared; this common substructure was removed and the remaining pair of substructures 
stored as potential bioisosteres.  Some of the replacements were generic, in that they 
occurred frequently throughout the MDDR, while others were identified only within specific 
therapeutic classes.   
 
A focus on the identification of topological equivalences inevitably means that less account 
is taken of physicochemical properties that may be of particular importance in the context of 
bioactivity.  Both Ertl et al. [14] and Holliday et al. [15] have reported work in which a 
substituent is characterised by computed physicochemical properties of various sorts.  The 
first of these represents a substituent by a vector of properties that are computed for the 
substituent as a whole; related ideas have been reported recently by Zhu et al. in work on the 
measurement of superstructure similarity in the design of reaction schemes [16].  The more 
complex system described by Holliday et al. represents a substituent by a series of vectors 
that encode the sum of the atomic properties at increasing numbers of bonds away from the 
point of attachment of the substituent.  The more detailed representation thus takes account 
of both the physicochemical characteristics of a substituent and its topology (and, implicitly, 
of its geometry in the case of low-flexibility substituents).  The resulting similarities have 
been used successfully for both database searching and QSAR [15, 17].   
 
Finally, there is IsoStar, which is a knowledge base containing information on the geometries 
of non-bonded interactions between specified pairs of chemical groups [18, 19].  The 
geometric data is used to generate scatterplots showing all the possible positions of a chosen 
contact group around a chosen central group, thus providing an overview of the preferred 
orientations that allow a particular group-to-group interaction to take place.  Watson et al. 
have discussed geometric similarity measures based on these scatterplots, so as to identify 
groups that are oriented similarly with respect to a given central group, such as a key amino 
acid in a protein active site [20].  This study is perhaps the most closely related to the work 
reported here in that both approaches use X-ray crystallographic data as the basis for 
identifying pairs of similar substructures; however, our work identifies equivalences that are 
specific to a particular target, and that are hence more likely to be associated with changes in 
the biological activity of interest.  
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 METHODS 
 
Introduction 
Our techniques seek to identify potential bioisosteres within a set of ligands for a particular 
protein target.  In brief, each ligand within a dataset is chosen in turn to act as the reference 
ligand, which is then compared to all the other ligands in the dataset, each of which is 
referred to as a query ligand.  The query ligand is split into a set of fragments (the query 
fragments) to identify small regions within a pair of ligands that might be bioisosteric.  The 
potential bioisosteres are identified based on volume overlap between a query fragment and a 
region within the current reference ligand that occupies the same space as the query 
fragment.  The procedure is summarised in Figure 1, and explained in greater detail in the 
remainder of this section.  The majority of the software was written using the Scientific 
Vector Language (SVL) scripting language available in the Molecular Operating 
Environment (MOE) that has been developed by the Chemical Computing Group [21]. 
 
Alignment and splitting of the ligands 
The Protein Data Bank (PDB) was searched to retrieve sets of structures that all shared a 
common amino acid sequence and that all contained a ligand bound to the protein [22].  One 
of the structures was chosen to act as a template, and the protein coordinates in the other 
structures fitted to the coordinates for the protein in the chosen reference structure.  This 
fitting stage was carried out with an MOE 3D-alignment procedure that uses all of the 
protein backbone atoms for the superposition of the different structures of the common 
protein.  The ligands were then aligned by extracting them from the set of fitted protein 
structures.   
 
Each of the extracted ligands is broken down into a set of overlapping fragments by the 
breaking of appropriate bonds.  For example, Figure 3 shows the results obtained from 
splitting the molecule shown in Figure 2.  The output in Figure 3 is obtained by breaking all 
the single bonds within the molecule unless they are either ring bonds or bonds involving 
terminal atoms; the four bonds broken in the example molecule are shown by red lines in the 
figure.  The fragments are generated by breaking the identified bonds in all possible 
combinations, and this set of fragments is then filtered to remove those that contain just a 
single atom, e.g., the single nitrogen atom fragment in Figure 3.    
 
Identification of fragment pairs 
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Each query fragment is then compared with the current reference molecule to identify the 
reference-molecule atoms that best overlay the query fragment.  The fragment and the 
reference molecule are already aligned, and it is hence simple to score the overlaps between 
the query fragment and sections of the reference molecule to determine the best mapping.  
The mapping is based on the degree to which the two fragments overlap in terms of the 
volume of their constituent atoms.  Fragments with a high degree of overlap will occupy a 
similar position within the protein’s active site and are hence assumed to have a similar role 
within the ligand.   
 
Scoring reference molecule sections  
As mentioned previously, the best overlap of each query fragment with the reference 
molecule needs to be identified, the resulting overlap being called the reference fragment.  In 
order to do this, the reference molecule is split into sections, where a section is defined as 
being part of a molecule in which all the atoms within it are connected by ring bonds or 
multiple bonds.  The sections within a particular molecule can hence be identified by 
breaking all of its non-ring single bonds, as exemplified in Figure 4.   Here, the four single, 
non-ring bonds marked in red are split to generate the sections labelled 1-5 on the right-hand 
side of the figure.   
 
The sectioned reference molecule is then compared with the query fragment.  Sections 
consisting of only one atom are kept because these sections may overlap with the query 
fragment and therefore need to be retained as part of the reference fragment.  If these 
sections do not overlap with the query molecule then they are excluded from the reference 
fragment, thus ensuring that the smallest reference fragment is identified.   
 
Computing volume overlaps is time-consuming and so it was decided to measure the overlap 
between a reference section and a query fragment using an equation based on the distances 
between pairs of their constituent atoms, specifically, a simplified version of the SEAL 
scoring function developed by Kearsley and Smith [23].  The volume overlap for each atom 
within a specific section is computed with each atom in the query fragment, and these 
overlaps summed.  The sums for all the atoms within the section are then added together to 
create the overall section score. 
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where m and n are the numbers of atoms in the reference section and the query fragment, 
respectively.  An average score is calculated by dividing this value by the number of atoms 
within the section, and the resulting mean score used to determine whether this section 
should be included within the reference fragment: this is done if the mean score is at least 
0.5.  This procedure is illustrated in Figure 5, comparing the same reference molecule as in 
Figure 4 with a query fragment shown in orange.  Here, two of the five sections of the 
reference molecule score highly enough, compared to the query fragment, to be included in 
the reference fragment (as indicated by the ticks), but the other three are omitted (as 
indicated by crosses).  The two selected sections in Figure 5 hence comprise the fragment 
pair shown in Figure 6, with the two substructural moieties making equivalent hydrogen 
bonding interactions with the protein structure.  
 
Calculating the average overall score 
Once the fragment pair has been identified then an average overall score for the pair needs to 
be calculated: this score is used to determine whether the fragment pair should be saved and 
to rank the pairs in the results database.  The distances between each possible pairing of one 
atom from the query fragment and one atom from the reference fragment are calculated, and 
this information used to score the match.  The score computed is   
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where m and n are the numbers of atoms in the reference fragment and the query fragment, 
respectively.   
 
Fragment pairs scoring less than a cut-off value 0.7 are excluded from further consideration, 
thus removing poorly aligned fragment pairs.  In addition, a series of filters was applied so as 
to remove fragment pairs that could not meet one or more of several criteria that are 
necessary for a fragment pair to represent a potential bioisosteric pair [23].  Examples of 
such criteria include the following.  First, only query fragments containing 20 atoms or less 
and reference fragments containing more than one atom are considered.  Second, it is 
possible for the query fragment and the reference fragment to be identical (especially if the 
ligands in the dataset have structurally similar regions to each other); these pairs are 
obviously not bioisosteric and are hence also removed.  Third, disjointed reference fragments 
were removed: these arise when the sections of the reference molecule that scored highly 
enough to be part of the reference fragment were not all connected together within the 
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reference molecule.   
 
RESULTS AND DISCUSSION 
 
The procedure described above was run on several sets of ligands drawn from the PDB, as 
listed in Table 1.  It will be seen from this table that there are major variations in the 
numbers of distinct fragment pairs identified.  The number depends on several factors, 
including: the number of ligands within the dataset; whether the ligands all bind to the same 
active site within the protein (and hence occupy a similar space); and the structural diversity 
of the ligands (as structurally homogeneous ligands are likely to produce multiple non-
unique fragment pairs).  Even so, the procedure is sufficiently rapid in execution to enable 
datasets of the sort shown in Table 1 to be processed in 5-10 minutes on a Linux PC.   
 
Examples of the fragment pairs identified are shown in Figure 7.  In this figure, the fragment 
pair is shown on the left with the ligands the pair were derived from shown to the right of the 
fragment pair; and the reference ligand is always shown in purple with the query ligand in 
orange.  The results in Figure 7 demonstrate that our procedures are able to identify pairs of 
fragment substructures that occupy the same space within a protein’s active site, and that 
may function as target-specific bioisosteres.  Such pairs may be involved in the same 
molecular interactions (as is the case with the bioisosteres identified using IsoStar) but may 
instead have other roles, such as being part of the scaffold region or a linker.  Once the 
fragment pairs have been identified they can be made available for consideration by 
medicinal chemists working on that target as potential aids for lead optimisation.  Further 
examples of fragment pairs are shown in Figure 8, which illustrates the wide range of types 
of structural equivalence identified by our procedure.   
 
Several of the fragment pairs from Figure 8 are illustrated in Figure 9, which demonstrates 
the types of interaction identified by our procedure.  Each of these figures shows the aligned 
proteins together with the associated fragment pairs, illustrating the ways in which different 
substructures are able to make the same interactions with the protein.  Thus, Figure 9a shows 
a hydrogen bonding interaction in CDK4, and there is also a stacking of the aromatic rings 
above the amide in the protein; Figure 9b shows a hydrogen-bonding interaction in Factor 
Xa; Figure 9c shows a hydrophobic interaction in Factor Xa between the amide and the 
centres of the bicyclic rings; Figure 9d shows a hydrophobic interaction in tyrosine 
phosphatise between the phenylaniline and the rings; Figure 9e shows a polar interaction in 
tyrosine phosphatase between an arginine and carboxylate or phosphate (there are also two 
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interactions with backbond amides); Figure 9f shows a zinc binding interaction in MMP3 
involving carboxylate and hydroxymate, a well-known pairing. 
 
One of the principal applications of bioisosteres during lead optimisation is to enhance a 
molecule’s ADMET profile.  There is hence a need to link the substructural equivalences 
identified here with locally-generated physicochemical data.  Specifically, the data is 
scanned to find pairs of molecules that differ from one another just by that particular 
fragment pair.  The property data associated with such a molecule-pair is then used to 
compute ΔP, where P is the altered property.  The procedure is repeated for all molecule-
pairs with the chosen fragment-pair and the mean ΔP computed, so as to identify substituent 
replacements that are expected to improve the chosen property P.  A prototype system based 
on these ideas is now under development at Sanofi-Aventis.    
 
CONCLUSIONS 
 
There is a rapidly increasing number of ligand-protein complexes for which X-ray 
crystallographic data are available, with many important biological targets for which there 
are complexes with a range of different ligands.  The availability of such data provides a 
basis for the identification of bioisosteres that are target-specific.  The resulting bioisosteres 
might be expected to provide more reliable information when modifying an existing lead 
compound than do existing approaches, which are based either on empirical measures of 
inter-substituent similarity or on non-target-specific crystallographic data.  In this paper, we 
have described one such approach, in which ligands extracted from PDB ligand-protein 
complexes are aligned in 3D space to identify substructural features with high volume 
overlap that occur in approximately the same regions of geometric space.  Experiments with 
twelve sets of ligand-protein complexes demonstrate that our approach is both effective and 
efficient in operation in identifying potential substructural replacements.  These 
replacements may be used to provide a knowledge-based approach to the enhancement of the 
ADMET profile of a lead compound. 
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 Protein target Number of ligands Number of non-unique 
fragment pairs identified 
(scoring over 0.7) 
ACHE 63 125 
Beta-glucosidase 23 28 
CDK2 32 702 
CDK 12 136 
Factor XA 20 347 
HIV-1 protease 78 5837 
MAO 16 16 
MMP13 6 15 
MMP3 5 19 
PDE4 12 68 
Tyrosine kinase 3 0 
Tyrosine phosphatase 1b 33 585 
 
 
Table 1.  Results of the procedure using PDB datasets 
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 Extract a set of ligands from the PDB that are all complexed with the same protein. 
Align the ligands on the basis of the common protein structure.  
FOR each ligand DO 
Make it the reference ligand, RL 
FOR each of the remaining ligands DO 
Make it the query ligand, QL 
Split QL into fragments 
FOR each query fragment DO 
Score its volume overlap with RL 
Identify the best matching region in RL 
ENDDO 
ENDDO 
ENDDO 
 
Figure 1.  Overview of the bioisostere identification procedure 
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Figure 2.  Splitting of a ligand 
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Figure 3.  Fragments generated from the molecule shown in Figure 2 
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Figure 4.  A reference molecule broken down into five sections 
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Figure 5.  Selection of sections for inclusion in the reference fragment 
 
 
 
 
Figure 6.  The fragment pair resulting from Figure 5. 
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(b) 
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(c) 
 
Figure 7.  Fragment pairs identified from the CDK2 (a), CDK4 (b) and Factor Xa (c) 
datasets 
 
CDK4 (*) 
N
H
N
N
H
*
 
N
N
H
*
 
CDK4 
NH
NHO
*
*  
N N
NH
NH
*
*  
15
  
 
Factor Xa (*) 
N
NH2
*
 
N
H
N*
 
Factor Xa (*) 
S
*
*  * *  
Tyrosine 
phosphatase 
N
H*
*
 *
* I
 
Tyrosine 
phosphatase (*) 
 
*
NH
*  
S
O
NH
*
*
 
Tyrosine 
phosphatase 
* NH
O
*
 
* *  
Tyrosine 
phosphatase (*) 
* OH
O
 
P
OH
O OH
O
*
 
HIV1 protease 
N
*
 S
*
 
HIV1 protease 
*  *  
HIV1 protease 
*  
O
*  
16
  
 
HIV1 protease S
N
*
 *  
HIV1 protease 
S
N
*
 
O
*  
HIV1 protease 
N
H
*
*
 
N
*
*  
MMP3 (*) 
* OH
O
 
* NH
O
OH
 
MMP3 
N
N
*
*
*
 
N
**
*  
PDE4 
N
N
N
N
*
*  
N
N
N
N
O
O
*
*  
PDE4 
N
N N
N
*
*  
*
O
*  
 
Figure 8.  Examples of bioisosteric fragment pairs identified by our procedure.  
Starred examples are shown in Figure 9. 
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(a) Fragment-pair interactions in CDK4 
 
 
 
(b) Fragment-pair interactions in Factor Xa 
 
18
  
 
 
 
(c) Fragment-pair interactions in Factor Xa 
 
 
 
(d) Fragment-pair interactions in tyrosine phosphatase 
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(e) Fragment-pair interactions in tyrosine phosphatase 
 
 
 
(f) Fragment-pair interactions in MMP3 
Figure 9.  Examples of interactions made by bioisosteric fragment pairs 
20
  
 
